Top 5 Stocks to Buy Now
→ My feud with Zohran Mamdani (From Stansberry Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GrowGeneration Corp. stock logo
GRWG
GrowGeneration
$1.40
-4.8%		$1.48
$0.87
▼
$2.40
$88.33M2.49337,324 shs329,219 shs
Himax Technologies, Inc. stock logo
HIMX
Himax Technologies
$16.77
-9.5%		$16.84
$6.85
▼
$25.09
$3.23B2.254.08 million shs2.55 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$61.00
+2.8%		$50.93
$22.28
▼
$67.74
$23.55B1.056.95 million shs6.81 million shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GrowGeneration Corp. stock logo
GRWG
GrowGeneration
-4.76%-9.09%-21.79%+23.89%+33.33%
Himax Technologies, Inc. stock logo
HIMX
Himax Technologies
-9.55%-0.12%-20.29%+81.69%+90.78%
Moderna, Inc. stock logo
MRNA
Moderna
+2.78%+10.11%+30.12%+13.93%+137.63%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GrowGeneration Corp. stock logo
GRWG
GrowGeneration
$1.40
-4.8%		$1.48
$0.87
▼
$2.40
$88.33M2.49337,324 shs329,219 shs
Himax Technologies, Inc. stock logo
HIMX
Himax Technologies
$16.77
-9.5%		$16.84
$6.85
▼
$25.09
$3.23B2.254.08 million shs2.55 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$61.00
+2.8%		$50.93
$22.28
▼
$67.74
$23.55B1.056.95 million shs6.81 million shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GrowGeneration Corp. stock logo
GRWG
GrowGeneration
-4.76%-9.09%-21.79%+23.89%+33.33%
Himax Technologies, Inc. stock logo
HIMX
Himax Technologies
-9.55%-0.12%-20.29%+81.69%+90.78%
Moderna, Inc. stock logo
MRNA
Moderna
+2.78%+10.11%+30.12%+13.93%+137.63%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GrowGeneration Corp. stock logo
GRWG
GrowGeneration
1.67
ReduceN/AN/A
Himax Technologies, Inc. stock logo
HIMX
Himax Technologies
2.00
Hold$8.00-52.30% Downside
Moderna, Inc. stock logo
MRNA
Moderna
1.83
Reduce$36.60-40.00% Downside

Current Analyst Ratings Breakdown

Latest HIMX, GRWG, and MRNA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/18/2026
Moderna, Inc. stock logo
MRNA
Moderna
Jefferies Financial Group Inc. logo
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold
6/12/2026
Moderna, Inc. stock logo
MRNA
Moderna
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
6/9/2026
GrowGeneration Corp. stock logo
GRWG
GrowGeneration
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
6/8/2026
Moderna, Inc. stock logo
MRNA
Moderna
Bank of America Corporation logo
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetUnderperform$32.00 ➝ $34.00
5/27/2026
GrowGeneration Corp. stock logo
GRWG
GrowGeneration
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
5/26/2026
Moderna, Inc. stock logo
MRNA
Moderna
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral
5/13/2026
GrowGeneration Corp. stock logo
GRWG
GrowGeneration
Alliance Global Partners logo
Alliance Global Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral
5/12/2026
GrowGeneration Corp. stock logo
GRWG
GrowGeneration
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
5/4/2026
Moderna, Inc. stock logo
MRNA
Moderna
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$36.00 ➝ $45.00
5/4/2026
Moderna, Inc. stock logo
MRNA
Moderna
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetSector Perform$35.00 ➝ $38.00
5/1/2026
Moderna, Inc. stock logo
MRNA
Moderna
The Goldman Sachs Group, Inc. logo
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$43.00 ➝ $49.00
(Data available from 6/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GrowGeneration Corp. stock logo
GRWG
GrowGeneration
$161.74M0.52N/AN/A$1.63 per share0.86
Himax Technologies, Inc. stock logo
HIMX
Himax Technologies
$832.17M3.52$0.34 per share48.78$5.16 per share3.25
Moderna, Inc. stock logo
MRNA
Moderna
$1.94B12.45N/AN/A$22.14 per share2.76
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GrowGeneration Corp. stock logo
GRWG
GrowGeneration
-$24.05M-$0.32N/AN/AN/A-11.91%-19.50%-12.91%8/10/2026 (Estimated)
Himax Technologies, Inc. stock logo
HIMX
Himax Technologies
$43.94M$0.2085.5723.29N/A3.91%3.57%1.86%8/6/2026 (Estimated)
Moderna, Inc. stock logo
MRNA
Moderna
-$2.82B-$8.15N/AN/AN/A-143.55%-26.64%-19.32%7/31/2026 (Estimated)

Latest HIMX, GRWG, and MRNA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/12/2026Q1 2026
GrowGeneration Corp. stock logo
GRWG
GrowGeneration
-$0.09-$0.08+$0.01-$0.08$36.45 million$38.39 million
5/7/2026Q1 2026
Himax Technologies, Inc. stock logo
HIMX
Himax Technologies
$0.03$0.0460+$0.0160$0.0460$195.01 million$199.01 million
5/1/2026Q1 2026
Moderna, Inc. stock logo
MRNA
Moderna
-$3.02-$3.40-$0.38-$3.40$236.37 million$389.00 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
GrowGeneration Corp. stock logo
GRWG
GrowGeneration
N/AN/AN/AN/AN/A
Himax Technologies, Inc. stock logo
HIMX
Himax Technologies
$0.362.15%N/A180.00%N/A
Moderna, Inc. stock logo
MRNA
Moderna
N/AN/AN/AN/AN/A

Latest HIMX, GRWG, and MRNA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/7/2026
Himax Technologies, Inc. stock logo
HIMX
Himax Technologies
annual$0.25201.22%6/30/20266/30/20267/10/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GrowGeneration Corp. stock logo
GRWG
GrowGeneration
N/A
4.05
2.55
Himax Technologies, Inc. stock logo
HIMX
Himax Technologies
0.02
1.62
1.42
Moderna, Inc. stock logo
MRNA
Moderna
0.08
2.41
2.35

Institutional Ownership

CompanyInstitutional Ownership
GrowGeneration Corp. stock logo
GRWG
GrowGeneration
36.02%
Himax Technologies, Inc. stock logo
HIMX
Himax Technologies
69.81%
Moderna, Inc. stock logo
MRNA
Moderna
75.33%

Insider Ownership

CompanyInsider Ownership
GrowGeneration Corp. stock logo
GRWG
GrowGeneration
8.06%
Himax Technologies, Inc. stock logo
HIMX
Himax Technologies
31.50%
Moderna, Inc. stock logo
MRNA
Moderna
10.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
GrowGeneration Corp. stock logo
GRWG
GrowGeneration
69060.09 million55.25 millionOptionable
Himax Technologies, Inc. stock logo
HIMX
Himax Technologies
2,238174.43 million119.48 millionOptionable
Moderna, Inc. stock logo
MRNA
Moderna
4,700396.79 million353.93 millionOptionable

Recent News About These Companies

Barclays Sticks to Its Hold Rating for Moderna (MRNA)
June 23 at 8:15 PM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/MRNA/pressreleases/2597269/barclays-sticks-to-its-hold-rating-for-moderna-mrna/
Moderna: From Buy To Sell After 128.2% Surge (Rating Downgrade)
June 23 at 8:15 PM  |  seekingalpha.comhttps://seekingalpha.com/article/4916970-moderna-from-buy-to-sell-after-128-2-percent-surge-rating-downgrade
Moderna (MRNA) Rises As Market Takes a Dip: Key Facts
June 23 at 8:15 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/moderna-mrna-rises-market-takes-215005782.html
Moderna (MRNA) Rises As Market Takes a Dip: Key Facts
June 23 at 6:51 PM  |  zacks.comhttps://www.zacks.com/stock/news/2941769/moderna-mrna-rises-as-market-takes-a-dip-key-facts?cid=cs-stocknewsapi-ft-tale_of_the_tape|yseop_template_6v1-2941769
Moderna snaps after six-session winning streak
June 22 at 7:36 PM  |  seekingalpha.comhttps://seekingalpha.com/news/4605754-moderna-snaps-after-six-session-winning-streak
FDA panel backs 1st mRNA flu vaccine
June 22 at 7:36 PM  |  beckershospitalreview.comB
FDA Panel Backs Moderna’s mRNA-Based Influenza Vaccine for Adults 50+
June 22 at 7:36 PM  |  empr.comE
Should You Buy Moderna Before Aug. 5?
June 22 at 6:10 PM  |  fool.comhttps://www.fool.com/investing/2026/06/22/should-you-buy-moderna-before-aug-5/
Moderna’s mRNA flu vaccine passes FDA AdCom, review underway
June 22 at 9:35 AM  |  pharmaceutical-technology.comP
Moderna's mRNA flu vaccine backed by FDA advisers
June 20, 2026  |  msn.comhttps://www.msn.com/en-us/news/us/moderna-s-mrna-flu-vaccine-backed-by-fda-advisers/ar-AA25ZAQ8
Moderna Has Some Key Approvals Ahead. Is the Stock a Buy?
June 20, 2026  |  fool.comhttps://www.fool.com/investing/2026/06/20/moderna-key-approvals-ahead-stock-buy/
Virtu Financial LLC Takes $2.42 Million Position in Moderna, Inc. $MRNA
June 20, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-virtu-financial-llc-takes-242-million-position-in-moderna-inc-mrna-2026-06-20/
Moderna, Inc. $MRNA Shares Sold by Tobam
June 20, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-moderna-inc-mrna-shares-sold-by-tobam-2026-06-20/
Promising Biotech Stocks To Follow Today - June 19th
June 20, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30850578
FDA panel supports first mRNA-based flu vaccine
June 19, 2026  |  fox42kptm.comF
US FDA panel recommends first-ever mRNA flu shot for older adults: All about the Moderna vaccine
June 19, 2026  |  msn.comhttps://www.msn.com/en-in/health/other/us-fda-panel-recommends-first-ever-mrna-flu-shot-for-older-adults-all-about-the-moderna-vaccine/ar-AA263kt2
MRNA Up as Influenza Vaccine Wins Unanimous FDA Advisory Panel Backing
June 19, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/mrna-influenza-vaccine-wins-unanimous-120400660.html
MRNA Up as Influenza Vaccine Wins Unanimous FDA Advisory Panel Backing
June 19, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2939927/mrna-up-as-influenza-vaccine-wins-unanimous-fda-advisory-panel-backing?cid=cs-stocknewsapi-ft-analyst_blog|company_news_medical_sector-2939927
FDA Votes in Favor of Benefit-Risk Profile for Moderna’s Flu Vaccine
June 19, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/fda-votes-in-favor-of-benefit-risk-profile-for-moderna-s-flu-vaccine/ar-AA260cfj
Hamilton Wealth LLC Acquires New Stake in Moderna, Inc. $MRNA
June 19, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-hamilton-wealth-llc-acquires-new-stake-in-moderna-inc-mrna-2026-06-19/
FDA advisors unanimously vote to approve Moderna’s mRNA after agency drama
June 18, 2026  |  arstechnica.comA

New MarketBeat Followers Over Time

Media Sentiment Over Time

GrowGeneration stock logo

GrowGeneration NASDAQ:GRWG

$1.40 -0.07 (-4.76%)
Closing price 06/23/2026 04:00 PM Eastern
Extended Trading
$1.36 -0.04 (-3.07%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GrowGeneration Corp., through its subsidiaries, owns and operates retail hydroponic and organic gardening stores in the United States. The company engages in the marketing and distribution of nutrients, additives, growing media, lighting, and environmental control systems, as well as other indoor and outdoor growing products. It operates a chain of stores in California, Colorado, Michigan, Maine, Oklahoma, Oregon, Washington, Montana, New York, Ohio, Mississippi, Missouri, Arizona, Rhode Island, Florida, Massachusetts, Virginia, New Jersey, and New Mexico, as well as growgeneration.com, an online superstore for cultivators, a wholesale business for resellers, HRG Distribution, and benching, racking, and storage solutions and MMI. The company was formerly known as Easylife Corp. GrowGeneration Corp. was founded in 2008 and is based in Greenwood Village, Colorado.

Himax Technologies stock logo

Himax Technologies NASDAQ:HIMX

$16.77 -1.77 (-9.55%)
Closing price 06/23/2026 04:00 PM Eastern
Extended Trading
$17.16 +0.39 (+2.33%)
As of 05:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Himax Technologies, Inc., a fabless semiconductor company, provides display imaging processing technologies in China, Taiwan, the Philippines, Korea, Japan, Europe, and the United States. The company operates in two segments, Driver IC and Non-Driver Products. It offers display driver integrated circuits (ICs) and timing controllers that are used in televisions, PC monitors, laptops, mobile phones, tablets, automotive, ePaper devices, industrial displays, and other products. The company also provides automotive IC solutions, including traditional driver ICs; advanced in-cell touch and display driver integration; large touch and display driver integration; and local dimming timing controllers, as well as active matrix organic light-emitting diode (AMOLED) solutions, including AMOLED drivers, timing controllers, and touch controller ICs. In addition, it offers application specific IC services; liquid crystal on silicon and micro-electro mechanical system products; Power ICs; complementary metal oxide semiconductor image sensor products; wafer level optics products; 3D sensing products; and ultralow power WiseEye smart image sensing products. The company markets its display drivers to panel manufacturers, mobile device module manufacturers, and manufacturers of end-use products. Himax Technologies, Inc. was incorporated in 2001 and is headquartered in Tainan City, Taiwan.

Moderna stock logo

Moderna NASDAQ:MRNA

$61.00 +1.65 (+2.78%)
Closing price 06/23/2026 04:00 PM Eastern
Extended Trading
$61.35 +0.35 (+0.57%)
As of 04:49 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas